Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials
Authors
Keywords
-
Journal
EuroIntervention
Volume 8, Issue 5, Pages 599-606
Publisher
Europa Digital & Publishing
Online
2012-10-12
DOI
10.4244/eijv8i5a92
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents
- (2012) Lorenz Räber et al. CIRCULATION
- Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes Mellitus
- (2011) Gregg. W. Stone et al. CIRCULATION
- A New Era of Prospective Real-World Safety Evaluation
- (2011) Mitchell W. Krucoff et al. JACC-Cardiovascular Interventions
- Comparison of Everolimus- and Paclitaxel-Eluting Stents in Patients With Acute and Stable Coronary Syndromes
- (2011) David Planer et al. JACC-Cardiovascular Interventions
- Impact of the Everolimus-Eluting Stent on Stent Thrombosis
- (2011) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial
- (2011) Sigmund Silber et al. LANCET
- Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials
- (2011) Dean Kereiakes et al. EuroIntervention
- Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
- (2010) Laura Mauri et al. AMERICAN HEART JOURNAL
- Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
- (2010) Elvin Kedhi et al. LANCET
- Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
- (2010) Seung-Jung Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
- (2010) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
- (2010) Patrick W. Serruys et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents
- (2009) Gregg W. Stone et al. CIRCULATION
- Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction
- (2009) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
- (2009) Patrick W. Serruys et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
- (2008) Michael Joner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started